A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Lifestyle Modifications for Preventing and Treating Heart Failure
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes